These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35813868)

  • 1. Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma.
    Xie R; Wu J; Shang B; Cao C; Bi X; Shi H; Shou J; Guan Y
    J Oncol; 2022; 2022():3204189. PubMed ID: 35813868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
    Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
    Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma.
    Wu J; Wang YC; Xu WH; Luo WJ; Wan FN; Zhang HL; Ye DW; Qu YY; Zhu YP
    Onco Targets Ther; 2020; 13():10453-10464. PubMed ID: 33116625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 6. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
    Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
    Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
    Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Front Oncol; 2021; 11():630706. PubMed ID: 33968730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
    Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
    Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Liu X; Zhang W; Wang H; Zhu L; Xu K
    Front Oncol; 2021; 11():762629. PubMed ID: 35096573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
    Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
    Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
    Song W; Shao Y; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
    Front Mol Biosci; 2020; 7():565173. PubMed ID: 33324675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Al Sharie AH; Al Zu'bi YO; El-Elimat T; Al-Kammash K; Abu Lil A; Isawi IH; Al Sharie S; Abu Mousa BM; Al Malkawi AA; Alali FQ
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836529
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
    Zhang F; Liu L; Wu P; Li S; Wei D
    Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
    Gan J; Zhang H
    Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
    Liu S; Wang F; Tan W; Zhang L; Dai F; Wang Y; Fan Y; Yuan M; Yang D; Zheng Y; Deng Z; Liu Y; Cheng Y
    Cancer Cell Int; 2020; 20():519. PubMed ID: 33117084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
    Zhang C; Li Z; Qi F; Hu X; Luo J
    Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.